These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 3743615
21. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate). Vukovich RA, Foley JE, Brown B, Willard DA, Buckley M, O'Kelly D, Fitzgerald D, Tormey W, Darragh A. Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871 [Abstract] [Full Text] [Related]
22. Effects of a week's beta-adrenoceptor blockade with atenolol and metoprolol CR/ZOK on the response to exercise in healthy women aged 50 to 70 years. Patrick J, Bassey J, Morrant J, Macdonald I. J Clin Pharmacol; 1990 Feb; 30(S2):S108-16. PubMed ID: 2312773 [Abstract] [Full Text] [Related]
23. Effect of dual beta-blockade and calcium antagonism on endurance performance. Gordon NF, van Rensburg JP, van den Heever DP, Kalliatakis NB, Myburgh DP. Med Sci Sports Exerc; 1987 Feb; 19(1):1-6. PubMed ID: 2881183 [Abstract] [Full Text] [Related]
24. Adding beta-2 agonism does not improve beta-1 blockade exercise responses in hypertensives. Rueckert PA, Slane PR, Hanson P. Med Sci Sports Exerc; 1994 Aug; 26(8):945-50. PubMed ID: 7968427 [Abstract] [Full Text] [Related]
25. Effect of beta 1-selective and non-selective beta-blockade on work capacity and muscle metabolism. Kaiser P, Tesch PA, Frisk-Holmberg M, Juhlin-Dannfelt A, Kaijser L. Clin Physiol; 1986 Apr; 6(2):197-207. PubMed ID: 3006981 [Abstract] [Full Text] [Related]
26. Effects of oxprenolol on the intra-arterial blood pressure response to dynamic exercise in hypertensive men. Millar-Craig MW, Mann S, Balasubramanian V, Cashman P, Raftery EB. J Cardiovasc Pharmacol; 1981 Apr; 3(3):468-76. PubMed ID: 6168828 [Abstract] [Full Text] [Related]
27. Absorption and excretion of rapid and slow release oxprenolol and their effects on heart rate and blood pressure during exercise. Bobik A, Jennings GL, Korner PI, Ashley P, Jackman G. Br J Clin Pharmacol; 1979 Jun; 7(6):545-9. PubMed ID: 465276 [Abstract] [Full Text] [Related]
28. Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men. Vanhees L, Defoor JG, Schepers D, Lijnen P, Peeters BY, Lacante PH, Fagard RH. J Hypertens; 2000 Jan; 18(1):35-43. PubMed ID: 10678541 [Abstract] [Full Text] [Related]
29. Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during treadmill exercise: a study of celiprolol and atenolol. II. McLenachan JM, Grant S, Ford I, Henderson E, Dargie HJ. Am Heart J; 1991 Feb; 121(2 Pt 2):691-6. PubMed ID: 1671188 [Abstract] [Full Text] [Related]
30. Physical performance and muscle metabolism during beta-adrenergic blockade in man. Kaiser P. Acta Physiol Scand Suppl; 1984 Feb; 536():1-53. PubMed ID: 6151777 [Abstract] [Full Text] [Related]
31. Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning. Wolfel EE, Hiatt WR, Brammell HL, Carry MR, Ringel SP, Travis V, Horwitz LD. Circulation; 1986 Oct; 74(4):664-74. PubMed ID: 2875812 [Abstract] [Full Text] [Related]
32. Concentration-effect relationships for oxprenolol in patients with essential hypertension. McInnes GT, Brodie MJ. Br J Clin Pharmacol; 1988 May; 25(5):539-45. PubMed ID: 3408634 [Abstract] [Full Text] [Related]
33. Exercise training during long-term beta-blockade treatment in healthy subjects. Savin WM, Gordon EP, Kaplan SM, Hewitt BF, Harrison DC, Haskell WL. Am J Cardiol; 1985 Apr 26; 55(10):101D-109D. PubMed ID: 3993543 [Abstract] [Full Text] [Related]
34. Running performance as a function of the dose-response relationship to beta-adrenoceptor blockade. Kaiser P. Int J Sports Med; 1982 Feb 26; 3(1):29-32. PubMed ID: 6121762 [Abstract] [Full Text] [Related]
35. Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation. Kerr MJ, Harron DW, Kinney C, Shanks RG. Br J Clin Pharmacol; 1981 Dec 26; 12(6):869-71. PubMed ID: 6122463 [Abstract] [Full Text] [Related]
36. Effects of beta-adrenergic blockade on endurance and short-time performance in respect to individual muscle fiber composition. Kaiser P, Rössner S, Karlsson J. Int J Sports Med; 1981 Feb 26; 2(1):37-42. PubMed ID: 6120902 [Abstract] [Full Text] [Related]
37. Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris. Bowles MJ, Khurmi NS, O'Hara MJ, Raftery EB. Eur J Clin Pharmacol; 1987 Feb 26; 32(2):127-33. PubMed ID: 3556193 [Abstract] [Full Text] [Related]
38. Concentration-effect relationship of oxprenolol in healthy volunteers: a retrospective analysis. Racine-Poon A, Moppert J. Br J Clin Pharmacol; 1985 Feb 26; 19 Suppl 2(Suppl 2):143S-149S. PubMed ID: 4005116 [Abstract] [Full Text] [Related]
39. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris. Antalóczy Z, Kekes E. Zhongguo Yao Li Xue Bao; 1989 May 26; 10(3):222-6. PubMed ID: 2609991 [Abstract] [Full Text] [Related]
40. Effect of beta-blockade on the drift in O2 consumption during prolonged exercise. Kalis JK, Freund BJ, Joyner MJ, Jilka SM, Nittolo J, Wilmore JH. J Appl Physiol (1985); 1988 Feb 26; 64(2):753-8. PubMed ID: 3372432 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]